COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis

BACKGROUND: Despite overall improvement in breast cancer patient outcomes from earlier diagnosis and personalised treatment approaches, some patients continue to experience recurrence and incurable metastases. It is therefore imperative to understand the molecular changes that allow transition from...

Descripción completa

Detalles Bibliográficos
Autores principales: Hancock, Janelle L., Kalimutho, Murugan, Straube, Jasmin, Lim, Malcolm, Gresshoff, Irma, Saunus, Jodi M., Lee, Jason S., Lakhani, Sunil R., Simpson, Kaylene J., Bush, Ashley I., Anderson, Robin L., Khanna, Kum Kum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111822/
https://www.ncbi.nlm.nih.gov/pubmed/37072858
http://dx.doi.org/10.1186/s13046-023-02663-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111822/
https://www.ncbi.nlm.nih.gov/pubmed/37072858
http://dx.doi.org/10.1186/s13046-023-02663-8

Ejemplares similares